Big Move For Taiwan Liposome Company, Ltd.
Tue, May 25, 2021 at 05:30 PM
Taiwan Liposome Company, Ltd. (TLC:NASDAQ) soared at $6.37, representing a gain of 28.7%. The stock got featured on our News Catalysts scanner on Tue, May 25, 2021 at 11:50 AM in the 'MISCELLANEOUS' category. From Mon, May 10, 2021, the stock recorded 30.00% Up Days and 27.27% Green Days
The share price of the company has been moving sideways in recent weeks.
About Taiwan Liposome Company, Ltd. (TLC:NASDAQ)
Taiwan Liposome Co Ltd is a clinical-stage specialty pharmaceutical company. It mainly focuses on the development and commercialization of novel nanomedicines.
Top 10 Gainers:
- Pieris Pharmaceuticals, Inc. (PIRS:NASDAQ), 103.24%
- SPBC (SPBC:NASDAQ), 100%
- MSDA (MSDA:NASDAQ), 100%
- Flanigan's Enterprises, Inc. (BDL:NYSEMKT), 40.58%
- Moxian, Inc. (MOXC:NASDAQ), 30.33%
- Taiwan Liposome Company, Ltd. (TLC:NASDAQ), 28.69%
- Provention Bio, Inc. (PRVB:NASDAQ), 26.82%
- Reading International, Inc. (RDIB:NASDAQ), 26.81%
- Lianluo Smart Limited (LLIT:NASDAQ), 24.59%
- Friedman Industries, Incorporated (FRD:NYSEMKT), 24.36%